Global Medical Cannabis Market Size By Type (Tetrahydrocannabinol (THC), Cannabidiol (CBD)), By Application (Pain, Arthritis), By Region, And Segment Forecasts, 2023 to 2032

The Global Medical Cannabis Market was valued at USD 17.8 billion in 2023 and is projected to reach USD 55.4 billion by 2031, expanding at a CAGR of 15.4% during the forecast period from 2023 to 2031. The market's growth is fueled by increasing legalization of medical cannabis across various countries, growing acceptance of cannabis-based treatment options, and a rising prevalence of chronic diseases like cancer, arthritis, and neurological disorders. Medical cannabis has proven effective in managing pain, reducing nausea associated with chemotherapy, and treating conditions such as epilepsy and multiple sclerosis, making it a vital component in modern therapeutics.

Drivers

1. Legalization and Regulatory Support:

Governments worldwide are increasingly recognizing the medicinal value of cannabis, with legislation enabling its regulated use. Countries like Canada, Germany, Australia, and multiple U.S. states have established robust medical cannabis frameworks, propelling market expansion.

2. Growing Medical Applications:

Research highlighting the therapeutic benefits of cannabis for managing chronic pain, anxiety, PTSD, and other conditions has broadened its medical scope. This expanding clinical application is fostering demand across healthcare settings.

3. Increasing Geriatric and Chronic Disease Population:

Aging populations and the rising incidence of chronic illnesses globally have led to increased demand for alternative treatment options like medical cannabis, particularly in palliative care.

Restraints

1. Regulatory Disparities:

Despite increasing acceptance, differences in cannabis regulations across countries and regions remain a challenge, limiting market accessibility and consistency in product standards.

2. Limited Clinical Data and Stigma:

A lack of comprehensive long-term clinical studies, combined with the historical stigma surrounding cannabis, continues to hamper full-scale adoption by some healthcare professionals and patients.

Opportunity

1. Expansion in Emerging Markets:

Countries in Latin America, Asia-Pacific, and Africa are gradually reforming cannabis policies, providing untapped potential for international market players to expand operations and reach.

2. Pharmaceutical Innovations and New Product Development:

Development of novel cannabis-based formulations, such as capsules, sprays, and transdermal patches, tailored for specific conditions, is opening new frontiers in patient-centered care.

3. Investment Surge and Research Funding:

Rising investor interest and government grants for medical cannabis R&D are fostering innovation and market competitiveness.

Market by System Type Insights

Based on system type, the CBD-Dominant Medical Cannabis segment held the largest market share in 2023. Its popularity is driven by its non-psychoactive properties and effectiveness in treating conditions like anxiety, inflammation, and epilepsy. However, the THC-Dominant segment is expected to witness the fastest growth during the forecast period due to increasing acceptance of its use in pain management and appetite stimulation, particularly in oncology and palliative care.

Market by End-Use Insights

By end-use, the Pharmaceutical Industry segment dominated the market in 2023, accounting for over 50% of global revenue. The segment is poised for sustained growth owing to increasing integration of cannabis into prescription medications. Meanwhile, research institutions and hospitals are anticipated to see accelerated growth as clinical trials and scientific validation of cannabis-based treatments expand.

Market by Regional Insights

North America held the largest market share in 2023, driven by favorable regulations, a well-developed supply chain, and high public awareness. The U.S. and Canada are at the forefront due to established medical cannabis programs. The Asia-Pacific region is expected to witness the highest CAGR during the forecast period, supported by progressive policy changes, expanding medical tourism, and growing healthcare investments in countries like Thailand, Australia, and South Korea.

Competitive Scenario

Key players in the Global Medical Cannabis Market include:

Canopy Growth Corporation

Aurora Cannabis Inc.

GW Pharmaceuticals plc (a Jazz Pharmaceuticals company)

Tilray Brands, Inc.

Cronos Group

Curaleaf Holdings, Inc.

Green Thumb Industries

Trulieve Cannabis Corp.

Aphria Inc.

MedReleaf Corp.

These companies are investing in R&D, expanding cultivation capacity, and entering strategic alliances to gain a competitive edge. For instance:

In 2024, Tilray Brands launched a line of THC-infused oral strips tailored for patients with swallowing difficulties.

In 2023, GW Pharmaceuticals gained FDA approval for expanded use of Epidiolex in pediatric epilepsy.

Canopy Growth entered into a partnership with a German healthcare provider in 2023 to expand its European footprint.

Scope of Work – Global Medical Cannabis Market

Key Market Developments

2023: GW Pharmaceuticals received regulatory approval in the EU for a new cannabinoid-based oral solution targeting neuropathic pain.

2024: Curaleaf Holdings launched a telehealth platform integrating medical cannabis consultations with prescription services.

2025: Aurora Cannabis began clinical trials in collaboration with a U.S. university for cannabis efficacy in treating Alzheimer’s symptoms.

FAQs

1) What is the current market size of the Global Medical Cannabis Market?

The Global Medical Cannabis Market was valued at USD 17.8 billion in 2023.

2) What is the major growth driver of the Global Medical Cannabis Market?

The major growth driver is the increasing legalization and acceptance of medical cannabis for treating chronic and neurological disorders.

3) Which is the largest region during the forecast period in the Global Medical Cannabis Market?

North America is the largest region, owing to favorable regulatory frameworks and high product awareness.

4) Which segment accounted for the largest market share in the Global Medical Cannabis Market?

The CBD-Dominant segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Medical Cannabis Market?

Major players include Canopy Growth, Aurora Cannabis, GW Pharmaceuticals, Tilray, Cronos Group, and Curaleaf Holdings.